Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
ChemicalBook >   Product Catalog >  Biochemical Engineering >  Inhibitors

Inhibitors

Immunosuppressants protein tyrosine kinase Neuronal Signaling PI3K / Akt / mTOR Metabolism Cell Cycle Epigenetics Cytoskeletal Signaling Angiogenesis DNA damage Proteases Apoptosis Mitogen-activated protein kinase (MAPK) Endocrinology & Hormones GPCR & G Protein Transmembrane Transporters Protein tyrosine kinase /JAK / STAT TGF-beta / Smad Stem Cells & Wnt Nuclear transcription factor (NF-κB) Ubiquitin Microbiology Autophagy
More
Less

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information

Structure:
Chemical Name:
IKK Inhibitor III, BMS-345541
CAS:
445430-58-0
MF:
C14H17N5
Structure:
Chemical Name:
CYP3cide
CAS:
1390637-82-7
MF:
C26H32N8
Structure:
Chemical Name:
3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-
CAS:
120964-45-6
MF:
C12H15ClN4O3
Structure:
Chemical Name:
CEP-32496 (free base)
CAS:
1188910-76-0
MF:
C24H22F3N5O5
Structure:
Chemical Name:
Nodinitib-1
CAS:
799264-47-4
MF:
C14H13N3O2S
Structure:
Chemical Name:
ARRY-334543
CAS:
845272-21-1
MF:
C22H19ClN6O2S
Structure:
Chemical Name:
6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
CAS:
1139889-93-2
MF:
C17H14F2N2
Structure:
Chemical Name:
N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA
CAS:
792173-99-0
MF:
C17H13N5O2
Structure:
Chemical Name:
EHT1864
CAS:
754240-09-0
MF:
C25H27F3N2O4S2HCl
Structure:
Chemical Name:
5-Carboxy-8-hydroxyquinoline
CAS:
5852-78-8
MF:
C10H7NO3
Structure:
Chemical Name:
CNX-774
CAS:
1202759-32-7
MF:
C26H22FN7O3
Structure:
Chemical Name:
GNE 7915
CAS:
1351761-44-8
MF:
C19H21F4N5O3
Structure:
Chemical Name:
P 22077
CAS:
1247819-59-5
MF:
C12H7F2NO3S2
Structure:
Chemical Name:
AZD 9668
CAS:
848141-11-7
MF:
C25H22F3N5O4S
Structure:
Chemical Name:
PI-3065
CAS:
955977-50-1
MF:
C27H31FN6OS
Structure:
Chemical Name:
Lorlatinib
CAS:
1454846-35-5
MF:
C21H19FN6O2
Structure:
Chemical Name:
IPA-3
CAS:
42521-82-4
MF:
C20H14O2S2
Structure:
Chemical Name:
LDN-193189 HCl
CAS:
1062368-62-0
MF:
C25H23ClN6
Structure:
Chemical Name:
6-pentadecylsalicylic acid
CAS:
16611-84-0
MF:
C22H36O3
Structure:
Chemical Name:
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone
CAS:
571203-78-6
MF:
C30H31ClN4O4
Structure:
Chemical Name:
CGS 21680A
CAS:
124431-80-7
MF:
C23H30ClN7O6
Structure:
Chemical Name:
Tie2 kinase inhibitor
CAS:
948557-43-5
MF:
C26H21N3O2S
Structure:
Chemical Name:
BMS-794833
CAS:
1174046-72-0
MF:
C23H15ClF2N4O3
Structure:
Chemical Name:
KX2-391
CAS:
897016-82-9
MF:
C26H29N3O3
Structure:
Chemical Name:
Vinflunine Tartrate
CAS:
1201898-17-0
MF:
C49H60F2N4O14
Structure:
Chemical Name:
DBeQ
CAS:
177355-84-9
MF:
C22H20N4
Structure:
Chemical Name:
AKT Kinase Inhibitor
CAS:
842148-40-7
MF:
C16H19N7O3
Structure:
Chemical Name:
L-Phenylalanine, 4-[bis(2-chloroethyl)oxidoaMino]-, (Hydrochloride) (1:2)
CAS:
685898-44-6
MF:
C13H19Cl3N2O3
Structure:
Chemical Name:
GW791343 HCl
CAS:
309712-55-8
MF:
C20H27Cl3F2N4O
Structure:
Chemical Name:
TAK875
CAS:
1374598-80-7
MF:
C58H66O15S2
Structure:
Chemical Name:
RGFP 109
CAS:
1215493-56-3
MF:
C20H25N3O2
Structure:
Chemical Name:
Cabotegravir (GSK744, GSK1265744)
CAS:
1051375-10-0
MF:
C19H17F2N3O5
Structure:
Chemical Name:
Verdinexor (KPT-335)
CAS:
1392136-43-4
MF:
C18H12F6N6O
Structure:
Chemical Name:
BRD4770
CAS:
1374601-40-7
MF:
C25H23N3O3
Structure:
Chemical Name:
LDC1267
CAS:
1361030-48-9
MF:
C30H26F2N4O5
Structure:
Chemical Name:
VER-49009
CAS:
940289-57-6
MF:
C19H18ClN3O4
Structure:
Chemical Name:
OG-L002
CAS:
1357302-64-7
MF:
C15H15NO
Structure:
Chemical Name:
KPT-330
CAS:
1393477-72-9
MF:
C17H11F6N7O
Structure:
Chemical Name:
WAY100635
CAS:
1092679-51-0
MF:
C29H38N4O6
Structure:
Chemical Name:
LDC000067
CAS:
1073485-20-7
MF:
C18H18N4O3S
Structure:
Chemical Name:
WS3
CAS:
1421227-52-2
MF:
C28H30F3N7O3
Structure:
Chemical Name:
Raf265 derivative
CAS:
1942849-27-5
MF:
C23H14F6N6O
Structure:
Chemical Name:
LMK-235
CAS:
1418033-25-6
MF:
C15H22N2O4
Structure:
Chemical Name:
Cathepsin Inhibitor 1
CAS:
225120-65-0
MF:
C20H24ClN5O2
Structure:
Chemical Name:
Deltarasin
CAS:
1440898-61-2
MF:
C40H37N5O
Structure:
Chemical Name:
GSK-2110183C
CAS:
1047644-62-1
MF:
C18H17Cl2FN4OS
Structure:
Chemical Name:
BS-181 HCl
CAS:
1397219-81-6
MF:
C22H33ClN6
Structure:
Chemical Name:
RGFP966
CAS:
1396841-57-8
MF:
C21H19FN4O
Structure:
Chemical Name:
ReModelin hydrobroMide
CAS:
1622921-15-6
MF:
C15H15BrN4S
Structure:
Chemical Name:
WIKI4
CAS:
838818-26-1
MF:
C29H23N5O3S
Structure:
Chemical Name:
FTI 277 HYDROCHLORIDE
CAS:
180977-34-8
MF:
C22H30ClN3O3S2
Structure:
Chemical Name:
PD 151746
CAS:
179461-52-0
MF:
C11H8FNO2S
Structure:
Chemical Name:
Ferrostatin-1 (Fer-1)
CAS:
347174-05-4
MF:
C15H22N2O2
Structure:
Chemical Name:
IEM 1754 dihydrobroMide
CAS:
162831-31-4
MF:
C16H32Br2N2
Structure:
Chemical Name:
LB 42708
CAS:
226929-39-1
MF:
C30H27BrN4O2
Structure:
Chemical Name:
BI-97C1
CAS:
1228108-65-3
MF:
C42H40N2O8
Structure:
Chemical Name:
SR2516
CAS:
1061353-68-1
MF:
C25H26F3N5O3
Structure:
Chemical Name:
Tubastatin-A
CAS:
1252003-15-8
MF:
C20H21N3O2
Structure:
Chemical Name:
PI-1840
CAS:
1401223-22-0
MF:
C22H26N4O3
Structure:
Chemical Name:
SCR7
CAS:
1533426-72-0
MF:
C18H14N4OS
Structure:
Chemical Name:
2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide
CAS:
304896-28-4
MF:
C23H13Cl2N3O2
Structure:
Chemical Name:
MI-3 (Menin-MLL Inhibitor)
CAS:
1271738-59-0
MF:
C18H25N5S2
Structure:
Chemical Name:
CPI-203
CAS:
1446144-04-2
MF:
C19H18ClN5OS
Structure:
Chemical Name:
4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide
CAS:
953769-46-5
MF:
C20H22N4O3S
Structure:
Chemical Name:
HO-3867
CAS:
1172133-28-6
MF:
C28H30F2N2O2
Structure:
Chemical Name:
WHI-P97
CAS:
211555-05-4
MF:
C16H13Br2N3O3
Structure:
Chemical Name:
AZD 2932
CAS:
883986-34-3
MF:
C24H25N5O4
Structure:
Chemical Name:
LFM-A13
CAS:
244240-24-2
MF:
C11H8Br2N2O2
Structure:
Chemical Name:
ZM 39923 HCl
CAS:
1021868-92-7
MF:
C23H26ClNO
Structure:
Chemical Name:
BMX-IN-1
CAS:
1431525-23-3
MF:
C29H24N4O4S
Structure:
Chemical Name:
NSC697923
CAS:
343351-67-7
MF:
C11H9NO5S
Structure:
Chemical Name:
GSK1324726A (I-BET726)
CAS:
1300031-52-0
MF:
C25H23ClN2O3
Structure:
Chemical Name:
BV6
CAS:
1001600-56-1
MF:
C70H96N10O8
Structure:
Chemical Name:
BAF-312(SiponiMod)
CAS:
1230487-00-9
MF:
C29H35F3N2O3
Structure:
Chemical Name:
PFI3
CAS:
1819363-80-8
MF:
C19H19N3O2
Structure:
Chemical Name:
PFI-2
CAS:
1627676-59-8
MF:
C23H25F4N3O3S
Structure:
Chemical Name:
MG149
CAS:
1243583-85-8
MF:
C22H28O3
Structure:
Chemical Name:
ARQ 621
CAS:
1095253-39-6
MF:
C28H24Cl2FN5O2
Structure:
Chemical Name:
CH5138303
CAS:
959763-06-5
MF:
C19H18ClN5O2S
Structure:
Chemical Name:
ISRIB (trans-isoMer)
CAS:
1597403-47-8
MF:
C22H24Cl2N2O4
Structure:
Chemical Name:
CAY10683 (SantacruzaMate A)
CAS:
1477949-42-0
MF:
C15H22N2O3
Structure:
Chemical Name:
Dizocilpine
CAS:
77086-21-6
MF:
C16H15N
Structure:
Chemical Name:
SBE 13 hydrochloride
CAS:
1052532-15-6
MF:
C24H28Cl2N2O4
Structure:
Chemical Name:
BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-
CAS:
1186206-79-0
MF:
C32H32F3N5O2S
Structure:
Chemical Name:
GZD 824
CAS:
1257628-77-5
MF:
C29H27F3N6O
Structure:
Chemical Name:
GZD824
CAS:
1421783-64-3
MF:
C31H35F3N6O7S2
Structure:
Chemical Name:
2H-IMidazole-2-thione, 5-(aMinoMethyl)-1-[(2R)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-,
CAS:
195881-94-8
MF:
C14H16ClF2N3S
Structure:
Chemical Name:
ME0328
CAS:
1445251-22-8
MF:
C19H19N3O2
Structure:
Chemical Name:
YH239-EE
CAS:
1364488-67-4
MF:
C25H27Cl2N3O4
Structure:
Chemical Name:
Defactinib
CAS:
1073154-85-4
MF:
C20H21F3N8O3S
Structure:
Chemical Name:
1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, hydrochloride (1:1)
CAS:
198480-56-7
MF:
C30H35ClN2O3
Structure:
Chemical Name:
Triapine
CAS:
200933-27-3
MF:
C7H9N5S
Structure:
Chemical Name:
4-ThiazolecarboxaMide, N-(6-benzoyl-1H-benziMidazol-2-yl)-2-(1-thieno[3,2-d]pyriMidin-4-yl-4-piperidinyl)-
CAS:
913822-46-5
MF:
C29H23N7O2S2
Structure:
Chemical Name:
BIX 01294
CAS:
1392399-03-9
MF:
C28H41Cl3N6O2
Structure:
Chemical Name:
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine
CAS:
1394076-92-6
MF:
C19H22N6O3S
Structure:
Chemical Name:
K-Ras inhibitor
CAS:
1469338-01-9
MF:
C20H30ClN3O2S3
Structure:
Chemical Name:
LDN-214117
CAS:
1627503-67-6
MF:
C25H29N3O3
Structure:
Chemical Name:
SH-4-54
CAS:
1456632-40-8
MF:
C29H27F5N2O5S
Structure:
Chemical Name:
MHY1485
CAS:
326914-06-1
MF:
C17H21N7O4
Structure:
Chemical Name:
GSK-LSD1
CAS:
1431368-48-7
MF:
C14H20N2